Clinically Symptomatic Respiratory Illness — Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Citation(s)
A Multicenter, Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly